Track Zhong Ji Longevity Science Group Limited's EBIT ($-31M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2026
Trailing 12 months ending Jun 30, 2026
The latest EBIT for 0767.HK is $-31M as of June 2026. That compares with $12M in the prior-year period — down 356.2% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside Zhong Ji Longevity Science Group Limited's historical trend and sector peers before judging valuation or financial health.
Over the past year, 0767.HK's EBIT moved from $12M to $-31M — a 356.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Zhong Ji Longevity Science Group Limited's operating scale or balance-sheet position.
Against its sector companies, 0767.HK currently prints $-31M for EBIT, while the sector average sits near $2.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Zhong Ji Longevity Science Group Limited's growth, margins, and balance sheet.
A EBIT figure of $-31M for 0767.HK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.
After noting 0767.HK's EBIT ($-31M), review year-over-year change from $12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.